Navigation Links
Differing reactions to anti clotting drugs may be due to genetic variation.,,

People who take anti clotting drugs like warfarin may react differently to the drug because of their genetic makeup.//

A sizable population of the world takes anti clotting medications in the event of heart attacks, stroke or major surgery to check harmful clotting of blood. However the difference in the reactions to the drugs have foxed the physicians for long and made it difficult to standardize the proper dosage of the drug. A little change in dose often may result in more reactions to blood flow.

Researchers of University of Washington in Seattle had discovered the variations in a gene that alters the way people respond to blood clotting medications. The gene encodes the CYP2C9 enzyme that metabolizes the anti clot drug and thus accounts for almost 10% variations of the reactions to the drug warfarin.

When are patients are tested for variations in reactions to medications, the tests mostly concentrate on the sex, age, weight and medical history of the patients. It may take months of visits to the physicians to find out the right dose for the patient even then. Genetic variations are often not considered here. The new research will emphasize the study of people’s reaction to medications and their genetic coding, also called pharmacogenetics.

Reference: National Institutes of Health, news release, June 2005
'"/>




Page: 1

Related medicine news :

1. Differing Ideas on Management of Alzheimer’s diseas
2. ZYBAN, The smoking cessation drug marked for its adverse reactions
3. Lupin flour may cause peanut allergy like reactions
4. Arsenic poisoning reactions can be traced to genes
5. stents Result in allergic reactions
6. Aspirin surpasses Modern Anti-clotting Drugs
7. Enduring anti-clotting treatment avails heart patients
8. Treatment over a longer period for blood clotting
9. Gum disease may be caused by blood clotting gene
10. Anlene brand of milk products will carry warnings about blood-clotting risks
11. Bivalirudin, a new anti-clotting drug may be a safer option for treatment of acute coronary conditions
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... ... April 21, 2017 , ... Contrary to popular perception, ... is declining—and at noteworthy rates. Between 2002 and 2014, Salas-Wright and his colleagues ... violence in the United States. The study, Trends in Fighting and Violence ...
(Date:4/21/2017)... SALT LAKE CITY, Utah (PRWEB) , ... April ... ... leading provider of wilderness therapy treatment for adolescents and young adults, has kicked ... Thursday, April 20th-Sunday, April 23rd. This year’s theme is “Attachment Informed Therapy ...
(Date:4/21/2017)... ... 2017 , ... Young Asset Protection, an insurance provider and ... greater Pittsburgh metropolitan region, is joining forces with the local chapter of the ... , Variety the Children’s Charity is a national organization dedicated to empowering, enabling, ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... The adage ... Flex House, the next project in the company’s esteemed VISION House demonstration project series. ... use exactly the amount of resources they need to live affordably and abundantly without ...
(Date:4/21/2017)... ... April 21, 2017 , ... The ... of Record (AOR) for Theravent, Inc. , the makers of a revolutionary ... Foundation Consumer Healthcare, is now working to expand distribution in anticipation of a ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Eyevensys, a private biotechnology company developing its ... that enables the safe, local, sustained production of therapeutic ... of ophthalmic diseases, announces it has received approval from ... to advance its technology into clinical development. ... The EyeCET platform uses ...
(Date:4/19/2017)... The Mobile X-Ray product segment is the most ... the forecast period Mobile X-Ray segment is the ... X-Ray devices market, which is estimated to be valued at ... CAGR of 7% over the forecast period. Mobile X-Ray segment ... US$ 100 Mn in 2017 over 2016. The segment,s revenue ...
(Date:4/19/2017)... 19, 2017 The Global Effective Microorganisms ... 2022 report has covered and analysed the potential of Global ... market size, shares and growth factors. The report identifies and ... opportunities in the global market. ... Browse 152 Tables and Figures, 6 Major Company Profiles, ...
Breaking Medicine Technology: